At what age should average risk individuals start colonoscopy (colon cancer screening) screening?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Colorectal Cancer Screening for Average-Risk Individuals

Colorectal cancer screening should begin at age 45 for all average-risk individuals. 1

Current Recommendations

The most recent guidelines from major professional societies have updated their recommendations for when to begin colorectal cancer screening in average-risk individuals:

  • U.S. Multi-Society Task Force (MSTF) 2021: Suggests offering CRC screening to all average-risk individuals age 45-49 (weak recommendation; low-quality evidence) and recommends screening for all average-risk individuals beginning at age 50 (strong recommendation, high-quality evidence) 1

  • United States Preventive Services Task Force (USPSTF) 2021: Recommends screening for colorectal cancer in adults aged 45 to 49 years (Grade B recommendation) and in adults aged 50 to 75 years (Grade A recommendation) 1

  • American Cancer Society (ACS) 2018: Recommends that adults aged 45 and older with average risk undergo regular screening 1

Rationale for Starting at Age 45

The recommendation to begin screening at age 45 is based on several important factors:

  • Increasing CRC incidence in younger adults: Incidence rates for 45-49 year-olds now match incidence in populations that were previously eligible for screening 1

  • Similar disease biology: Molecular studies show that tumors in 40-49 year-olds have similar biology to those in individuals over 50 1

  • Comparable yield of screening: Data show that the rate of advanced colorectal neoplasia in average-risk individuals ages 45-49 is similar to rates observed in screening cohorts of those ages 50-59 1

  • Positive modeling studies: Previous modeling studies demonstrate that benefits of screening outweigh harms in average-risk 45-49 year-olds, with acceptable cost-effectiveness 1

When to Stop Screening

Screening should continue until:

  • Age 75 for most individuals who are up to date with screening and have negative prior screening tests 1

  • For individuals aged 76-85, screening should be individualized based on:

    • Prior screening history
    • Life expectancy
    • Overall health status
    • Patient preferences 1
  • Do not screen individuals age 86 and older: Overall mortality risk and risk of adverse events associated with colonoscopy outweigh the life expectancy benefits 1

Special Considerations for Family History

For individuals with a family history of colorectal cancer:

  • First-degree relative diagnosed at age ≥60: Begin screening at age 40 with standard average-risk screening options 1, 2

  • First-degree relative diagnosed at age <60 or two first-degree relatives with CRC: Begin colonoscopy screening at age 40 or 10 years before the earliest diagnosis in the relative, whichever comes first, and repeat every 5 years 1, 2

  • First-degree relative with documented advanced adenoma: Follow the same recommendations as for those with a first-degree relative with CRC 2

Common Pitfalls and Caveats

  1. Failure to recognize increased risk in younger patients: CRC incidence is rising in persons under age 50, so thorough evaluation of young persons with suspected colorectal bleeding is essential 3

  2. Overscreening elderly patients: For individuals over 75 who have had negative prior screenings, the risks of colonoscopy may outweigh the benefits 1

  3. Missing advanced neoplasia with limited screening methods: In studies of asymptomatic 50-59 year-olds, flexible sigmoidoscopy would have missed up to 38% of polyps found on colonoscopy 4

  4. Inadequate follow-up of positive non-colonoscopy screening tests: All positive results on non-colonoscopy screening tests should be followed up with timely colonoscopy 1

  5. Poor compliance in high-risk groups: Special efforts should be made to ensure screening compliance in younger individuals with a family history of CRC 1

By following these evidence-based recommendations, clinicians can optimize colorectal cancer prevention and early detection, ultimately reducing CRC morbidity and mortality.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Colorectal Cancer Screening Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.